Odyssey Math Tuition launches a Secondary 1 online math tuition elearning course in Singapore, featuring a proprietary ...

Gibson highlighted, "Recursion has a tremendous amount of potential catalysts coming in the next 18 months," referencing the pipeline, partnerships, and platform advancements. He reported, "a pro ...

Recursion Pharmaceuticals remains a high-cash-burn, premium-valued biotech with unproven clinical success despite a recent 47% rally. RXRX's next 18 months are catalyst-rich, but key pipeline assets ...

According to InvestingPro analysis, Recursion maintains strong liquidity with a current ratio of 3.58, though the company faces profitability challenges. On the same day, Gibson also converted 100,000 ...

Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the second neuro map designed to accelerate treatments for a wide range of neurolog ...

I’m not ready to pull the fire alarm yet, but I’m smelling something, and it might be smoke. Watching these first few Denver Nuggets games, I can’t help but ask myself, “Where’s Cameron Johnson?” ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Dr. Grande's covers topics related to counselor education and supervision including but not limited to mental health, human behavior, relationship dynamics, psychopathology, personality theory, true ...

In 2015, AI in drug discovery was still a theoretical pursuit – exciting, but unproven. A few early start-ups were applying deep learning to virtual screening and molecular modelling, but the industry ...

Steven Nickolas is a writer and has 10+ years of experience working as a consultant to retail and institutional investors. Suzanne is a content marketer, writer, and fact-checker. She holds a Bachelor ...

Decision-making inherently involves cause–effect relationships that introduce causal challenges. We argue that reliable algorithms for decision-making need to build upon causal reasoning. Addressing ...